Table of Contents
1. Analyst View
2. Research Overview
3. In Vitro Diagnostic Market Overview
3.1 Introduction
3.2 What is In Vitro Diagnostics?
3.3 Market Size and Growth
3.4 Market Share of Top Players
4. Market Drivers
4.1 Chronic and Infectious Diseases
4.2 New Technologies
4.3 Emerging Markets
4.4 Diversifying Applications
4.5 Healthcare Infrastructure
5. Clinical Segmentation Outlook 2012
5.1 Point of Care Diagnostics
5.2 Clinical Chemistry and Immunochemistry
5.3 Molecular Diagnostics
5.4 Microbiology
5.5 Hemostasis
5.6 Hematology
5.7 Immunohematology
6. Segmentation by Indication (Current and Future Scenario-2012)
6.1 Diabetes
6.2 Cardiovascular
6.3 Cancer
6.4 HIV
6.5 Tuberculosis
7. Geographical Segmentation (Current and Future Scenario-2012)
7.1 North America
7.1.1 United States
7.1.2 Canada
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 United Kingdom
7.2.5 Spain
7.2.6 Other European Countries
7.3 Japan
7.4 Rest of the World
7.4.1 China
7.4.2 India
7.4.3 Turkey
7.4.4 Brazil
7.4.5 Mexico
8. Roadblocks
8.1 Regulatory and Reimbursement Issues
8.2 R&D and Short Product Lifecycle
9. Key Player Profiles
9.1 Roche Holding Ltd.
9.2 Abbott Laboratories
9.3 Siemens AG
9.4 Beckman Coulter, Inc.
9.5 Ortho-Clinical Diagnostics
List of Figures:
Figure 3-1: Global-In Vitro Diagnostic Market (Billion US$), 2007-2009
Figure 3-2: Global-Forecast for In Vitro Diagnostic Market (Billion US$), 2010-2012
Figure 3-3: Global-In Vitro Diagnostic Market by Player (%)
Figure 5-1: Global-In Vitro Diagnostic Market by Clinical Segment (%), 2008
Figure 5-2: Global-Forecast for In Vitro Diagnostic Market by Clinical Segment (%), 2012
Figure 5-3: Global-Point of Care Diagnostic Market (Billion US$), 2007-2009
Figure 5-4: Global-Point of Care Diagnostic Market by Segment (%), 2007
Figure 5-5: Global-Point of Care Diagnostic Market by Distribution (%), 2007
Figure 5-6: Global-Forecast for Point of Care Diagnostic Market (Billion US$), 2010-2012
Figure 5-7: Global-Clinical Chemistry and Immunochemistry Market (Billion US$), 2007-2009
Figure 5-8: Global-Forecast for Clinical Chemistry and Immunochemistry Market (Billion US$), 2010-2012
Figure 5-9: Global-Molecular Diagnostic Market (Billion US$), 2007-2009
Figure 5-10: Global-Forecast for Molecular Diagnostic Market (Billion US$), 2010-2012
Figure 5-11: Global-Microbiology Diagnostic Market (Billion US$), 2007-2009
Figure 5-12: Global-Forecast for Microbiology Diagnostic Market (Billion US$), 2010-2012
Figure 5-13: Global-Hemostasis Diagnostic Market (Billion US$), 2007-2009
Figure 5-14: Global-Forecast for Hemostasis Diagnostic Market (Billion US$), 2010-2012
Figure 5-15: Global-Forecast for Hematology Market (Billion US$), 2010-2012
Figure 5-16: Global-Immunohematology Diagnostic Market (Billion US$), 2007-2009
Figure 5-17: Global-Forecast for Immunohematology Diagnostic Market (Billion US$), 2010-2012
Figure 6-1: Global-Diabetic Population (Million), 2007 & 2025
Figure 6-2: Global-Blood Glucose Monitoring Market (Billion US$), 2007-2009
Figure 6-3: Global-Share of Players in Blood Glucose Monitoring Market (2005)
Figure 6-4: Global-Forecast for Blood Glucose Monitoring Market (Billion US$), 2010-2012
Figure 6-5: Global-Cardiovascular Diagnostic Market (Billion US$), 2007-2009
Figure 6-6: Global-Forecast for Cardiovascular Diagnostic Market (Billion US$), 2010-2012
Figure 6-7: Global-Cancer Diagnostic Market (Billion US$), 2008 & 2012
Figure 6-8: Global-HIV Diagnostic and Monitoring Market (Million US$), 2004, 2008 & 2012
Figure 6-9: Global-Tuberculosis Diagnostic Market by Segment (%), 2005
Figure 6-10: Global-Tuberculosis Detection and Monitoring Market by Segment (%), 2005
Figure 7-1: Global-In Vitro Diagnostic Market by Region (%), 2008
Figure 7-2: Global-Forecast for In Vitro Diagnostic Market by Region (%), 2012
Figure 7-3: US-In Vitro Diagnostic Market (Billion US$), 2007-2009
Figure 7-4: US-In Vitro Diagnostic Market by Segment (%), 2007
Figure 7-5: US-Labs in IVD Market by Type (%), 2008
Figure 7-6: US-Forecast for In Vitro Diagnostic Market (Billion US$), 2010-2012
Figure 7-7: Canada-In Vitro Diagnostic Market (Million US$), 2004 & 2007-2009
Figure 7-8: Canada-Forecast for In Vitro Diagnostic Market (Million US$), 2010-2012
Figure 7-9: Europe-In Vitro Diagnostic Market (Billion Euro), 2007-2009
Figure 7-10: Europe-In Vitro Diagnostic Market by Country (%), 2008
Figure 7-11: Europe-Forecast for In Vitro Diagnostic Market (Billion Euro), 2010-2012
Figure 7-12: Germany-In Vitro Diagnostic Market (Million Euro), 2007-2009
Figure 7-13: Germany-Forecast for In Vitro Diagnostic Market (Million Euro), 2010-2012
Figure 7-14: France-In Vitro Diagnostic Market (Million Euro), 2007-2009
Figure 7-15: France-In Vitro Diagnostic Reagents Market by Segment (%), 2005
Figure 7-16: France-Forecast for In Vitro Diagnostic Market (Million Euro), 2010-2012
Figure 7-17: Italy-In Vitro Diagnostic Market (Million Euro), 2007-2009
Figure 7-18: Italy-In Vitro Diagnostic Market by Segment (%), 2008
Figure 7-19: Italy-In Vitro Diagnostic Reagents Market by Segment (%), 2008
Figure 7-20: Italy-Forecast for In Vitro Diagnostic Market (Million Euro), 2010-2012
Figure 7-21: UK-In Vitro Diagnostic Market (Million Euro), 2007-2009
Figure 7-22: UK-Forecast for In Vitro Diagnostic Market (Million Euro), 2010-2012
Figure 7-23: Spain-In Vitro Diagnostic Market (Million Euro), 2007-2009
Figure 7-24: Spain-Forecast for In Vitro Diagnostic Market (Million Euro), 2010-2012
Figure 7-25: Japan-In Vitro Diagnostic Market (Billion Yen), 2007-2009
Figure 7-26: Japan-In Vitro Diagnostic Market by Segment (%), 2007
Figure 7-27: Japan-Share of Players in In Vitro Diagnostic Market (2004)
Figure 7-28: Japan-Forecast for In Vitro Diagnostic Market (Billion Yen), 2010-2012
Figure 7-29: China-In Vitro Diagnostic Market (Million US$), 2007-2009
Figure 7-30: China-In Vitro Diagnostic Market by Segment (%), 2007
Figure 7-31: China-Forecast for In Vitro Diagnostic Market (Million US$), 2010-2012
Figure 7-32: India-In Vitro Diagnostic Market (Million US$), 2007-2009
Figure 7-33: India-In Vitro Diagnostic Market by Segment (%), 2007
Figure 7-34: India-Forecast for In Vitro Diagnostic Market (Million US$), 2010-2012
Figure 7-35: Turkey-In Vitro Diagnostic Market (Million US$), 2006-2009
Figure 7-36: Turkey-Share of Clinical Laboratories by Type (2004)
Figure 7-37: Turkey-Forecast for In Vitro Diagnostic Market (Million US$), 2010-2012
Figure 7-38: Brazil-In Vitro Diagnostic Market (Million US$), 2007-2009
Figure 7-39: Brazil-In Vitro Diagnostic Market by Segment (%), 2007
Figure 7-40: Brazil-Forecast for In Vitro Diagnostic Market (Million US$), 2010-2012
Figure 7-41: Mexico-In Vitro Diagnostic Market (Million US$), 2007-2009
Figure 7-42: Mexico-In Vitro Diagnostic Market by Segment (%), 2007
Figure 7-43: Mexico-Forecast for In Vitro Diagnostic Market (Million US$), 2010-2012
Figure 8-1: Global-R&D Expenditure on IVD in Comparison to Other Industrial Sectors (%)
List of Tables:
Table 3-1: Commonly Used In Vitro and In Vivo Diagnostic Tests
Table 5-1: Global-In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2008
Table 5-2: Global-Forecast for CAGR of In Vitro Diagnostic Market by Clinical Segment (%), 2010 to 2012
Table 5-3: Global-Forecast for In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2012
Table 5-4: Global-Share of Top Players in Clinical Chemistry and Immunochemistry Market (2007)
Table 5-5: Global-Share of Top Players in Molecular Diagnostic Market (2007)
Table 5-6: Global-Share of Top Players in Microbiology Diagnostic Market (2007)
Table 5-7: Global-Share of Top Players in Hemostasis Diagnostic Market (2007)
Table 6-1: Global-Cancer Diagnostic Market by Type (Million US$), 2002-2008
Table 7-1: Germany-In Vitro Diagnostic Market by Segment (Million Euro), 2008
Table 7-2: Other European Countries-In Vitro Diagnostic Market (Million Euro), 2007